Shao‐Chen Yang

771 total citations · 1 hit paper
13 papers, 641 citations indexed

About

Shao‐Chen Yang is a scholar working on Oncology, Immunology and Biomedical Engineering. According to data from OpenAlex, Shao‐Chen Yang has authored 13 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Immunology and 5 papers in Biomedical Engineering. Recurrent topics in Shao‐Chen Yang's work include Cancer Immunotherapy and Biomarkers (8 papers), Nanoplatforms for cancer theranostics (5 papers) and Immune cells in cancer (4 papers). Shao‐Chen Yang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Nanoplatforms for cancer theranostics (5 papers) and Immune cells in cancer (4 papers). Shao‐Chen Yang collaborates with scholars based in China and Hong Kong. Shao‐Chen Yang's co-authors include Zhi‐Jun Sun, Qi‐Chao Yang, Zhigang Xu, Tian Zhang, Leilei Yang, Xianbin Ma, Mengyun Liang, Yao Xiao, Yao Xiao and Shuo Wang and has published in prestigious journals such as Chemical Communications, Small and British Journal of Cancer.

In The Last Decade

Shao‐Chen Yang

12 papers receiving 639 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Microenvironment‐Responsive Prodrug‐Induced Pyroptosis Boosts Cancer Immunotherapy

2021 266 citations Yao Xiao, Tian Zhang et al. Advanced Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shao‐Chen Yang China	10	334	321	206	146	122	13	641
Zhounan Zhu China	8	228 0.7×	259 0.8×	215 1.0×	150 1.0×	90 0.7×	9	591
Xuemeng Guo China	12	218 0.7×	242 0.8×	221 1.1×	75 0.5×	73 0.6×	28	584
Duo Gao China	12	150 0.4×	346 1.1×	209 1.0×	136 0.9×	76 0.6×	40	626
Karthik Tiruthani United States	11	295 0.9×	228 0.7×	314 1.5×	279 1.9×	94 0.8×	17	746
Yuyue Zhao China	15	246 0.7×	198 0.6×	210 1.0×	117 0.8×	64 0.5×	31	682
Xiaoqin Lai China	6	159 0.5×	320 1.0×	210 1.0×	132 0.9×	81 0.7×	15	540
Bai Ji China	12	273 0.8×	215 0.7×	93 0.5×	160 1.1×	154 1.3×	36	618
Chayanon Ngambenjawong United States	10	498 1.5×	244 0.8×	472 2.3×	245 1.7×	103 0.8×	15	1.0k
Feifei Yang China	16	282 0.8×	239 0.7×	340 1.7×	211 1.4×	215 1.8×	32	837
Manisit Das United States	13	279 0.8×	342 1.1×	338 1.6×	302 2.1×	215 1.8×	17	810

Countries citing papers authored by Shao‐Chen Yang

Since Specialization

Citations

This map shows the geographic impact of Shao‐Chen Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shao‐Chen Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shao‐Chen Yang more than expected).

Fields of papers citing papers by Shao‐Chen Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shao‐Chen Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shao‐Chen Yang. The network helps show where Shao‐Chen Yang may publish in the future.

Co-authorship network of co-authors of Shao‐Chen Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Shao‐Chen Yang. A scholar is included among the top collaborators of Shao‐Chen Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shao‐Chen Yang. Shao‐Chen Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Qiu, Zhen, et al.. (2025). Enhancing Startup Financing Success Prediction Based on Social Media Sentiment. Systems. 13(7). 520–520.

2.

Mao, Liang, Junjie Zhou, Yao Xiao, et al.. (2023). Immunogenic hypofractionated radiotherapy sensitising head and neck squamous cell carcinoma to anti-PD-L1 therapy in MDSC-dependent manner. British Journal of Cancer. 128(11). 2126–2139. 18 indexed citations

3.

Zhang, Mengjie, Mengyun Liang, Shao‐Chen Yang, et al.. (2023). Bioengineering of BRAF and COX2 inhibitor nanogels to boost the immunotherapy of melanomaviapyroptosis. Chemical Communications. 59(7). 932–935. 13 indexed citations

4.

Yang, Qi‐Chao, Xianbin Ma, Yao Xiao, et al.. (2022). Engineering prodrug nanomicelles as pyroptosis inducer for codelivery of PI3K/mTOR and CDK inhibitors to enhance antitumor immunity. Acta Pharmaceutica Sinica B. 12(7). 3139–3155. 23 indexed citations

5.

Yang, Shao‐Chen, Wuyin Wang, Junjie Zhou, et al.. (2022). Inhibition of DNMT1 potentiates antitumor immunity in oral squamous cell carcinoma. International Immunopharmacology. 111. 109113–109113. 25 indexed citations

6.

Ma, Xianbin, Zhi‐Zhong Wu, Shu‐Cheng Wan, et al.. (2022). pH-responsive nanoprodrugs combining a Src inhibitor and chemotherapy to potentiate antitumor immunity via pyroptosis in head and neck cancer. Acta Biomaterialia. 154. 497–509. 25 indexed citations

7.

Ma, Xianbin, Shao‐Chen Yang, Tian Zhang, et al.. (2021). Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy. Acta Pharmaceutica Sinica B. 12(1). 451–466. 101 indexed citations

8.

Mao, Liang, Yao Xiao, Qi‐Chao Yang, et al.. (2021). TIGIT/CD155 blockade enhances anti-PD-L1 therapy in head and neck squamous cell carcinoma by targeting myeloid-derived suppressor cells. Oral Oncology. 121. 105472–105472. 46 indexed citations

9.

Xiao, Yao, Tian Zhang, Xianbin Ma, et al.. (2021). Microenvironment‐Responsive Prodrug‐Induced Pyroptosis Boosts Cancer Immunotherapy. Advanced Science. 8(24). e2101840–e2101840. 266 indexed citations breakdown →

10.

Li, Hao, Hong‐Gang Xiong, Yao Xiao, et al.. (2020). Long Non-coding RNA LINC02195 as a Regulator of MHC I Molecules and Favorable Prognostic Marker for Head and Neck Squamous Cell Carcinoma. Frontiers in Oncology. 10. 615–615. 37 indexed citations

11.

Yang, Qi‐Chao, Hao Li, Yao Xiao, et al.. (2020). Expression of inositol polyphosphate 4‐phosphatase type II and the prognosis of oral squamous cell carcinoma. European Journal Of Oral Sciences. 128(1). 37–45. 2 indexed citations

12.

Bai, Shuang, Leilei Yang, Yajun Wang, et al.. (2020). Prodrug‐Based Versatile Nanomedicine for Enhancing Cancer Immunotherapy by Increasing Immunogenic Cell Death. Small. 16(19). e2000214–e2000214. 84 indexed citations

13.

Xiao, Yao, Hao Li, Cong‐Cong Wu, et al.. (2019). Expression and clinicopathologic significance of coxsackie–adenovirus receptor in oral squamous cell carcinoma. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 129(2). 141–148. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact